-

Sleep Number Corporation Shareholder Alert: Robbins LLP Reminds Investors that Sleep Number Corporation (SNBR) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Sleep Number Corporation (NASDAQ: SNBR) common stock between February 18, 2021 and July 20, 2021, for violations of the Securities Exchange Act of 1934. Sleep Number, with its subsidiaries, provides sleep solutions and services in the U.S.

If you suffered a loss due to Sleep Number Corporation's misconduct, click here.

Sleep Number Corporation (SNBR) Misled Investors Regarding its Supply Chain Flexibility

According to the complaint, during the class period, defendants touted the Company's vertical integration and ability to "manage inventory to support a more customer-focused supply chain." Specifically, Sleep Number's CFO stated: "While explosive demand has certainly stressed our supply chain, we are benefiting [sic] from strong relationships with our global suppliers and are expediting components as needed to fulfill customers’ desire for our proven quality sleep solutions. … The flexibility and resilience we built into our global supply chain is also enabling rapid expansion of our fulfillment capacity, including the addition of 2 new assembly distribution centers in Dallas and Tampa here in the first quarter of 2021."

In reality, on February 14, 2021, Winter Storm Uri battered the Gulf Coast of the U.S., including the states of Texas and Louisiana. A nationwide shortage of foam ensued due to the closure and work stoppages of plants in Texas and Louisiana that are the primary North American-based suppliers for the petrochemical components used in foam manufacture. As a result, Sleep Number experienced significant undisclosed supply chain disruptions that hindered its ability to meet surging customer demand for its products, which used foam as a necessary component material.

On July 20, 2021, Sleep Number announced its financial results for its second fiscal quarter ended June 30, 2021, revealing it had missed consensus estimates on the top and bottom line for the quarter and blaming the disappointing results in significant part on "near-term supply constraints" and component shortages. On this news, the price of Sleep Number stock fell nearly 13%, to close at $97.78 per share on July 21, 2021.

If you purchased shares of Sleep Number Corporation (SNBR) between February 18, 2021, and July 20, 2021, you have until February 14, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Sleep Number Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome. 

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Snowflake Inc. Class Action Reminder - Robbins LLP Encourages SNOW Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Snowflake Inc. (NYSE: SNOW) Class A common stock between June 27, 2023 and February 28, 2024. Snowflake is a software company that provides cloud data storage that enables customers to consolidate data onto data-driven applications and share data for the purpose of running analytics and other processes. For more information, submit a form, ema...

Corcept Therapeutics Incorporated Class Action Reminder – Robbins LLP Encourages CORT Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol.For more information, submit a...

uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period? September 24, 2025 – October 31, 2025What...
Back to Newsroom